Lumexa Imaging Holdings, Inc. Investing Cash Flow
Lumexa Imaging Holdings, Inc. (LMRI) reported Investing Cash Flow of -$18.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13
- Lumexa Imaging Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$13.64M.
- Lumexa Imaging Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$5.27M.
- Lumexa Imaging Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was -$4.17M.
- Lumexa Imaging Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was -$720.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month |
|---|---|---|
| 2026-06-30 | -$13.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$18.91M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$5.27M 10-Q · filed 2026-05-12 | |
| 2025-06-30 | -$4.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$4.89M 10-Q · filed 2026-08-13 |
| 2025-03-31 | -$720.00K 10-Q · filed 2026-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B |